EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Loctek Ergonomic Technology Corp Class A (300729) fair value: what the stock is really worth

As of Sep 22, 2026: fair value of Loctek Ergonomic Technology Corp Class A ¥14.99, price ¥11.60, upside +29.2%, quality 35 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Industrials · CN · ISIN CNE1000035N9

LE Broad data Sep 24, 2026

Loctek Ergonomic Technology Corp Class A

300729 · SHE

SpeculativeUpside exists, but weak quality makes the signal speculative.

Fair value ¥14.99 · Undervalued (+29%)
!Quality 35/100
!Mixed Growth (revenue 5y +28.2 %/yr)
!Thin margins · 3.1% net margin (TTM)
!Low debt · negative free cash flow
·2.59% dividend yield
!Mixed vs. peers (6/13)
!Narrow moat 35/100
!Weak on past: 23 out of 100
Watch Loctek Ergonomic Technology Corp Class A for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

¥23.99 ¥9.58 Fair Value ¥14.99 Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range ¥9.58 – ¥23.99 · fair‑value band ¥9.86 – ¥19.94 · the ¥11.60 price screens below the ¥14.99 fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow Loctek Ergonomic Technology Corp Class A in your weekly email

Every Wednesday you see whether Loctek Ergonomic Technology Corp Class A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Loctek Ergonomic Technology Corp. researches and develops, manufactures, and sells smart home and healthy office products in China and internationally.

Show more

Loctek Ergonomic Technology Corp. researches and develops, manufactures, and sells smart home and healthy office products in China and internationally. The company offers LINEAR drive smart office lift table, smart lift workstation, smart lift children's study table, fitness office chair, and smart electric beds, etc.; and provide cross-border e-commerce public overseas warehouse innovative comprehensive services, including first-leg shipping, overseas warehousing, last-leg delivery, and return shipping for small and medium-sized enterprises. It also involved in e-commerce logistics business and warehousing services. Loctek Ergonomic Technology Corp. was founded in 2002 and is based in Ningbo, China.

Stock analysis

Loctek Ergonomic Technology Corp Class A (300729) currently trades at ¥11.60, while our model-based Fair Value estimate is ¥14.99, implying the stock looks roughly 22.6% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ¥26.79 per share, and 12 of the 16 models we run sit above the ¥11.60 price.

Bear case: the Dividend Discount group reads lowest at ¥6.03, and 4 of the 16 models stay below the price. Evidence for this calculation is high.

Scenario range: ¥9.86 (bear) to ¥19.94 (bull), the price of ¥11.60 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 35/100 (below-average quality), in the Industrials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Loctek Ergonomic Technology Corp Class A reported revenue of 6.7B CNY in FY2025 versus 2.9B CNY in FY2021, a compound +23.7%/yr. Reported net income was 259M CNY in FY2025, compounding +8.9%/yr from FY2021.

Key figures

Market cap 4.0B CNY (≈ $592M) · P/E ratio 19.0 · P/S ratio 0.73 · EPS (TTM) ¥0.6100 · Dividend yield 2.6% · Net margin 3.9% · Return on equity 5.6% · Return on assets (EBIT) 5.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (medium confidence).

What moves the price

The share trades about 24% below its 52-week high and 21% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −50% fair-value upside, at 29%, 300729 screens cheaper than that median.

Fair Value models

Bear ¥9.86 Fair Value ¥14.99 Bull ¥19.94
Model Each model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (¥0.2268 per share) are deliberately not added. Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence Evidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income ¥8.38 ¥8.68 ¥8.69 76
EPV ¥11.15 ¥12.28 ¥13.22 74
ROIC Compounder ¥11.39 ¥14.07 ¥16.40 72
All 16 models by family
Earnings-Based
Graham-Dodd ¥5.16 ¥36.02 ¥50.55 63
Lynch FV ¥15.07 ¥21.53 ¥27.98 61
PEG = 1.0 ¥15.07 ¥21.53 ¥27.98 57
EPV ¥11.15 ¥12.28 ¥13.22 74
Dividend Discount
Gordon GGM ¥3.66 ¥6.60 ¥9.09 68
DDM Multi-Stage ¥3.66 ¥6.03 ¥7.05 67
Multiples
P/E Multiple ¥11.96 ¥15.95 ¥19.94 63
P/S Multiple ¥9.68 ¥12.91 ¥16.14 58
P/B Multiple ¥9.68 ¥12.91 ¥16.14 55
EV/EBIT ¥18.25 ¥23.39 ¥28.52 66
EV/EBITDA ¥31.25 ¥40.71 ¥50.17 67
EV/Revenue ¥13.85 ¥18.56 ¥23.26 54
Asset-Based
NCAV (Graham) ¥5.46 ¥7.31 ¥10.92 54
Economic Profit
Residual Income ¥8.38 ¥8.68 ¥8.69 76
ROIC Compounder ¥11.39 ¥14.07 ¥16.40 72
Growth Earnings
Growth-Adj P/E ¥18.75 ¥26.79 ¥34.82 67

Open the full fair value analysis →

Notify me when 300729 reaches fair value

Put 300729 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 35/100

Of which business quality 38 · Market factors (momentum, volatility) 43

Profitability 34
Margins and returns on capital today
Quality Growth 51
Are margins and returns improving?
Cashflow 44
Earnings quality: real cash, not paper profit
Fin. Strength 46
Balance sheet, leverage, solvency risk
Investment 13
Disciplined investing over empire-building
Low Volatility 84
Calm price path (market factor)
Momentum 29
Price trend over the last 3–12 months (market factor)
52W Momentum 21
Distance to the 52-week high (market factor)
Net Issuance 32
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality Growth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+18.4%
Revenue growth 3 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+27.9%
Revenue growth 5 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.2%
Start year 2020 (pandemic). Over 10 years: +33.4% a year
Revenue growth 17 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+27.8%
What shareholders gained per year (last 5 years) What the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+5.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year+3.0%
Dividend (yield on the price)2.6%
Pace: 5 vs 10 years Two data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.3% vs 9%, slowing
Profit margin 2020 to 2025 Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.12% → 6%
Start year 2020 (pandemic)

Watch 300729, get fair value alerts →

Compare Loctek Ergonomic Technology Corp Class A with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Business Equipment & Supplies · 75 stocks

Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 35 · Bottom 25%
Fair Value upside +29% · Above median
Profitability
Return on equity (TTM) 6% · Above median
Return on assets 2% · Below median
Net margin (TTM) 3% · Below median
Operating margin (TTM) 4% · Below median
Growth and dividend
Revenue growth −3% · Below median
Dividend yield (TTM) 2.6% · Below median
Balance sheet
Debt / equity 0.32× · Highest 25%

Valuation Multiplesvs Business Equipment & Supplies median · lower = cheaper

P/E (TTM) 19.0× · Cheaper than median
P/B 1.06× · Cheaper than median
P/S (TTM) 0.59× · Cheaper than median
EV/EBITDA 6.1× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)72 · sector 29
FUTURE (revenue growth)0 · sector 19
PAST (return on equity)23 · sector 20
HEALTH (low debt)84 · sector 98
DIVIDEND (yield)52 · sector 52

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Business Equipment & Supplies stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Loctek Ergonomic Technology Corp Class A Fair Value". https://www.fairvalue-calculator.com/stock/300729

Frequently asked questions

Is Loctek Ergonomic Technology Corp Class A (300729) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥14.99 versus a price of ¥11.60, about +29% upside (undervalued).
What is the fair value of 300729?
Our model-based fair value for Loctek Ergonomic Technology Corp Class A is ¥14.99 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥11.60.
What is the quality score of 300729?
Loctek Ergonomic Technology Corp Class A has a Quality Score of 35/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Loctek Ergonomic Technology Corp Class A (300729)?
Our model-based price target is the fair value of ¥14.99 (as of Sep 24, 2026) from 16 valuation models. Cautious scenario ¥9.86, optimistic scenario ¥19.94. It is a calculation from audited fundamentals, not an analyst target.
What is the Loctek Ergonomic Technology Corp Class A stock forecast for 2026?
Our models put fair value at ¥14.99, about +29% upside versus a price of ¥11.60 (undervalued). Cautious scenario ¥9.86, optimistic scenario ¥19.94. The calculation is refreshed regularly with new filings.
What is the revenue of Loctek Ergonomic Technology Corp Class A (300729)?
Loctek Ergonomic Technology Corp Class A reported trailing-twelve-month revenue of about 6.7B CNY (latest available figure, as of Sep 24, 2026).
Does Loctek Ergonomic Technology Corp Class A pay a dividend?
Loctek Ergonomic Technology Corp Class A currently shows a dividend yield of about 2.59% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Loctek Ergonomic Technology Corp Class A (300729)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Loctek Ergonomic Technology Corp Class A it is ¥14.99 per share (as of Sep 24, 2026), against a price of ¥11.60. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Loctek Ergonomic Technology Corp Class A stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 300729 trades below its calculated fair value: price ¥11.60, fair value ¥14.99, a gap of about +29% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 300729?
No. The price is what the market pays today (¥11.60); the fair value is what the company's own numbers justify (¥14.99). For Loctek Ergonomic Technology Corp Class A the two are ¥3.39 per share apart. That gap is exactly why we show both numbers side by side.
How much is Loctek Ergonomic Technology Corp Class A worth?
The market values Loctek Ergonomic Technology Corp Class A at about 4.0B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥11.60; our models calculate a fair value of ¥14.99 per share.
What do the bullish and bearish scenarios say about 300729?
Our models span a range for Loctek Ergonomic Technology Corp Class A: cautious scenario ¥9.86, base ¥14.99, optimistic ¥19.94 per share (as of Sep 24, 2026, price ¥11.60). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 300729?
Loctek Ergonomic Technology Corp Class A trades at a price-to-earnings ratio of 19.0 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥14.99 is built from several models across several years. Other multiples: P/B 1.1, P/S 0.6, EV/EBITDA 6.1.
How solid is the balance sheet of Loctek Ergonomic Technology Corp Class A (300729)?
Balance-sheet figures for Loctek Ergonomic Technology Corp Class A (as of Sep 24, 2026): return on equity 5.6%, debt of 0.32 per unit of equity. They feed the Quality Score of 35/100, which measures business quality independently of the share price.
How far is 300729 from its 52-week high?
Loctek Ergonomic Technology Corp Class A trades at ¥11.60, about 24% below its 52-week high of ¥15.17 and 21% above the low of ¥9.58 (as of Sep 22, 2026). Distance from the high says nothing about value: that is what the fair value of ¥14.99 is for.
Which stocks are comparable to Loctek Ergonomic Technology Corp Class A?
From the same area (Industrials) we also value GRG Banking Equipment Co, Shanghai M&G Stationery Inc, XGD Inc, DOMS Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Loctek Ergonomic Technology Corp Class A stock attractive at the current price?
The data as of Sep 24, 2026: price ¥11.60, calculated fair value ¥14.99 (+29%), Quality Score 35/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 300729 calculated?
We run Loctek Ergonomic Technology Corp Class A through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥14.99, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Loctek Ergonomic Technology Corp Class A currently trades 29 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Loctek Ergonomic Technology Corp Class A (300729)?
The closing price on Sep 22, 2026 was ¥11.60. Our model-based fair value is ¥14.99, about +29% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Loctek Ergonomic Technology Corp Class A right now?
A fairly wide model range (¥9.86 to ¥19.94) leaves room in how you read the outcome. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of Loctek Ergonomic Technology Corp Class A (300729) come from?
Earnings per share at Loctek Ergonomic Technology Corp Class A grew +20.6 % a year from 2013 to 2024. Broken into its drivers: revenue per share +22.8 %, EBIT margin −1.1 %, tax rate −0.2 %, residual (interest, one-offs) −0.6 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Loctek Ergonomic Technology Corp Class A

How large is the market capitalisation of Loctek Ergonomic Technology Corp Class A (300729)?
The market capitalisation of Loctek Ergonomic Technology Corp Class A is 4.0B CNY (≈ $592M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Loctek Ergonomic Technology Corp Class A (300729)?
The price-to-sales ratio of Loctek Ergonomic Technology Corp Class A is 0.73 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Loctek Ergonomic Technology Corp Class A (300729)?
Earnings per share at Loctek Ergonomic Technology Corp Class A are ¥0.6100 (price ÷ EPS = P/E 19.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Loctek Ergonomic Technology Corp Class A (300729)?
The dividend yield of Loctek Ergonomic Technology Corp Class A is 2.6% (payout 49.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Loctek Ergonomic Technology Corp Class A (300729)?
The net margin of Loctek Ergonomic Technology Corp Class A is 3.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Loctek Ergonomic Technology Corp Class A (300729)?
The return on equity (ROE) of Loctek Ergonomic Technology Corp Class A is 5.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Loctek Ergonomic Technology Corp Class A (300729)?
On an EBIT basis the return on assets of Loctek Ergonomic Technology Corp Class A is 5.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Loctek Ergonomic Technology Corp Class A (300729)?
The operating margin of Loctek Ergonomic Technology Corp Class A is 4.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Loctek Ergonomic Technology Corp Class A (300729)?
Revenue at Loctek Ergonomic Technology Corp Class A is growing −3.1% versus a year earlier (3y avg +27.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Loctek Ergonomic Technology Corp Class A (300729)?
Earnings per share at Loctek Ergonomic Technology Corp Class A are growing −98.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Loctek Ergonomic Technology Corp Class A (300729) generate?
The free cash flow of Loctek Ergonomic Technology Corp Class A is −59.4M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Loctek Ergonomic Technology Corp Class A (300729) carry?
The net debt of Loctek Ergonomic Technology Corp Class A is 1.9B CNY (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Loctek Ergonomic Technology Corp Class A in the live analysis

One click puts Loctek Ergonomic Technology Corp Class A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.